Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Detection of oncostatin M in human plasma and serum by a sensitive enzyme immunoassay.

Naemura JR, Radka SF.

Lymphokine Cytokine Res. 1993 Jun;12(3):187-90.

PMID:
8347766
2.
3.

Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop.

Gu ZJ, Costes V, Lu ZY, Zhang XG, Pitard V, Moreau JF, Bataille R, Wijdenes J, Rossi JF, Klein B.

Blood. 1996 Nov 15;88(10):3972-86.

4.

Determination of human tumor necrosis factor alpha by a highly sensitive enzyme immunoassay.

Hedayati M, Yazdanparast R, Azizi F.

Biochem Biophys Res Commun. 2001 Nov 23;289(1):295-8.

PMID:
11708815
5.
6.

Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.

Liu J, Spence MJ, Wallace PM, Forcier K, Hellström I, Vestal RE.

Cell Growth Differ. 1997 Jun;8(6):667-76.

8.

Abrogation of the antiproliferative activity of oncostatin M by a monoclonal antibody.

Radka SF, Naemura JR, Shoyab M.

Cytokine. 1992 May;4(3):221-6.

PMID:
1379836
9.
10.

Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture.

Richards CD, Shoyab M, Brown TJ, Gauldie J.

J Immunol. 1993 Jun 15;150(12):5596-603.

PMID:
8515078
11.

Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna immunoassay system.

St Ledger K, Agee SJ, Kasaian MT, Forlow SB, Durn BL, Minyard J, Lu QA, Todd J, Vesterqvist O, Burczynski ME.

J Immunol Methods. 2009 Oct 31;350(1-2):161-70. doi: 10.1016/j.jim.2009.08.012. Epub 2009 Sep 2.

PMID:
19732777
12.

Circulating interleukin-6 type cytokines in patients with systemic lupus erythematosus.

Robak E, Sysa-Jedrzejowska A, Stepień H, Robak T.

Eur Cytokine Netw. 1997 Sep;8(3):281-6.

13.

Accurate detection of maternal antibodies to HIV in newborn whole blood dried on filter paper.

Pappaioanou M, Kashamuka M, Behets F, Mbala S, Biyela K, Davachi F, George JR, Green TA, Dondero TJ, Heyward WL, et al.

AIDS. 1993 Apr;7(4):483-8.

PMID:
8507414
14.
15.

A highly sensitive enzyme immunoassay for evaluation of 2'-deoxycytidine plasma level as a prognostic marker for breast cancer chemotherapy.

Darwish IA, Mahmoud AM, Aboul-Fadl T, Al-Majed AR, Khalil NY.

Anal Chim Acta. 2009 Jan 26;632(2):266-71. doi: 10.1016/j.aca.2008.11.014. Epub 2008 Nov 17.

PMID:
19110103
16.

Spontaneous release of leukemia inhibitory factor and oncostatin-M is increased in supernatants of short-term organ cultures from lesional psoriatic skin.

Bonifati C, Mussi A, D'Auria L, Carducci M, Trento E, Cordiali-Fei P, Ameglio F.

Arch Dermatol Res. 1998 Jan-Feb;290(1-2):9-13.

PMID:
9522995
17.

Analytical performance and clinical utility of a sensitive immunoassay for determination of human cardiac troponin I.

Davies E, Gawad Y, Takahashi M, Shi Q, Lam P, Styba G, Lau A, Heeschen C, Usategui M, Jackowski G.

Clin Biochem. 1997 Aug;30(6):479-90.

PMID:
9316743
18.

The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis.

Okamoto H, Yamamura M, Morita Y, Harada S, Makino H, Ota Z.

Arthritis Rheum. 1997 Jun;40(6):1096-105.

PMID:
9182920
20.

Oncostatin M in the anti-inflammatory response.

Wahl AF, Wallace PM.

Ann Rheum Dis. 2001 Nov;60 Suppl 3:iii75-80. Review.

Supplemental Content

Support Center